Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
J Exp Med (1991) 173 (4): 931–939.
Currently there are no citedby results. Try again later.
